Advertisements

Protalix BioTherapeutics Inc. (DE) (PLX) Stock Quote

Detailed Quote for Protalix BioTherapeutics Inc. (DE) (PLX)
$ 0.93   -0.0699 (-6.99%) Volume: 2.7m 4:06 PM EDT Apr 28, 2017
After Hours:  $ 0.9243   -0.0057 (-0.61%) Volume: 19.21k 6:47 PM EDT Apr 28, 2017
Today 5d 1m 3m 1y more
Last Price
0.93
Change $
0.0699
Change %
6.99%
Tick
  
Bid
N/A
Bid Size
0
Ask
N/A
Ask Size
0
Open
0.99
High
1.00
Low
0.9035
Prev Close
0.9999
Last Trade
04/28/17
Volume
2.7m
52 Wk Hi
1.51460003
52 Wk Low
0.25999999
Market Cap
115.44m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
124,134,085
EPS (TTM)
-0.289999991
PE Ratio
N/A
Exchange
NYSE MKT
News and Media for Protalix BioTherapeutics Inc. (DE) (PLX)
Sector News | Topic News
News for Protalix BioTherapeutics Inc. (DE) (PLX)
Thu, Apr 20, 2017
8:17 PM Protalix BioTherapeutics Is Positioned Well For The Future - SeekingAlpha
Tue, Apr 18, 2017
7:30 AM Protalix BioTherapeutics Announces New Preclinical Results Demonstrating a Positive Effect of pegunigalsidase alfa (PRX-102) on Small-fiber Neuropathy in Fabry Disease Models Compared to Commercially Available Enzyme Replacement Therapies - GlobeNewswire
Wed, Apr 12, 2017
7:30 AM Protalix BioTherapeutics Announces Positive Results from Phase II Clinical Trial of alidornase alfa (AIR DNase(TM)) for the Treatment of Cystic Fibrosis - GlobeNewswire
Tue, Apr 04, 2017
8:15 AM Blog Coverage Kitov Received a $2 Million Filing Waiver from FDA - Accesswire
Thu, Mar 16, 2017
12:00 PM Protalix BioTherapeutics' (PLX) CEO Moshe Manor on Q4 2016 Results - Earnings Call Transcript - SeekingAlpha
8:04 AM Protalix BioTherapeutics beats by $0.09, misses on revenue - SeekingAlpha
8:00 AM Protalix BioTherapeutics Reports 2016 Full Year Results and Provides Corporate Update - GlobeNewswire
Wed, Mar 15, 2017
5:06 PM Protalix BioTherapeutics: Exploring Ulcerative Colitis - SeekingAlpha
Tue, Mar 14, 2017
9:58 AM Cerulean Pharma Attracts Investors and Possible Suitor, Protalix Returns to the Spotlight - Accesswire
8:25 AM Protalix continues up move, shares ahead 4% premarket - SeekingAlpha
Mon, Mar 13, 2017
12:47 PM Midday Gainers / Losers - SeekingAlpha
9:30 AM Today's Research Report on Trending Biotech Tickers: Protalix Biotherapeutics and Stemline Therapeutics - Accesswire
Thu, Mar 09, 2017
7:30 AM Protalix BioTherapeutics to Hold Full-Year 2016 Financial Results and Corporate Update Conference Call on March 16, 2017 - GlobeNewswire
Tue, Mar 07, 2017
9:17 AM Premarket Gainers / Losers as of 9:10 am - SeekingAlpha
Tue, Feb 21, 2017
5:17 PM Protalix BioTherapeutics: New Institutional Ownership Swells Ahead Of Major Catalysts - SeekingAlpha
Sat, Feb 18, 2017
10:28 AM InvestorsGuru.com 10 Filtered Mid-Day Market Movers Recap - Investors Guru
Tue, Feb 14, 2017
4:50 PM Protalix BioTherapeutics Announces Record Date for the 2017 Annual Meeting of Stockholders - GlobeNewswire
Mon, Feb 13, 2017
12:53 PM Midday Gainers / Losers - SeekingAlpha
11:26 AM Protalix continues up move, shares ahead 27% - SeekingAlpha
7:01 AM Protalix BioTherapeutics to Participate in the 13th Annual WORLDSymposium(TM) 2017 - GlobeNewswire
More News for PLX >>

Tags for Protalix BioTherapeutics Inc. (DE)

Research stocks or mutual funds related to Protalix BioTherapeutics Inc. (DE) by keywords or tags. Find companies that have a similar focus to PLX. The keywords below have been associated to PLX by either user submission or electronic means.

biotechnology company biotech research pharmaceuticals research pharmaceuticals international research patent market pharmaceutical market corporate communication generic pharmaceutical pharmaceutical investment pharma strategy biotechnology market pharmaceutical research and development annual report pharmaceutical manufacturing company dupont pharmaceuticals pharmaceutical advisory boards Biological Products pharma marketing pharmaceutical industry marketing pharmaceutical software pharma manufacturing pharma license pharmaceutical supply chain kv pharmaceutical company clinical research pharmaceutical cro pharmaceutical sales pharmaceutical distributors biotech corporation pharmaceutical development pharmaceutical sales rep pharmaceutical reports pharmaceutical magazine pharma product development pharmaceutical patent Drugs pharmaceutical industry news pharmaceutical manufacturing software corporate communications pharmaceutical conference pharmaceutical manufacturing pharmaceutical formulation pharma reports publicity contract pharmaceutical pharmaceutical consulting pharmaceutical industry news release pharmaceutical studies pharmaceutical strategy